Cargando…
Adenyl cyclase activator forskolin protects against Huntington's disease-like neurodegenerative disorders
Long term suppression of succinate dehydrogenase by selective inhibitor 3-nitropropionic acid has been used in rodents to model Huntington's disease where mitochondrial dysfunction and oxidative damages are primary pathological hallmarks for neuronal damage. Improvements in learning and memory...
Autores principales: | Mehan, Sidharth, Parveen, Shaba, Kalra, Sanjeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361515/ https://www.ncbi.nlm.nih.gov/pubmed/28400813 http://dx.doi.org/10.4103/1673-5374.200812 |
Ejemplares similares
-
Adenylate cyclase activator forskolin alleviates intracerebroventricular propionic acid-induced mitochondrial dysfunction of autistic rats
por: Mehan, Sidharth, et al.
Publicado: (2019) -
Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases
por: Lee, Eun Hye, et al.
Publicado: (2014) -
Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases
por: Solés-Tarrés, Irene, et al.
Publicado: (2020) -
Characterization of Adenylyl Cyclase Isoform 6 Residues Interacting with Forskolin
por: Bhatia, Vikram, et al.
Publicado: (2023) -
Adenylate-cyclase activity in platelets of patients with obsessive-compulsive disorder
por: Marazziti, D, et al.
Publicado: (2009)